Raymond James & Associates’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-74,113
| Closed | -$660K | – | 4044 |
|
|
2024
Q2 | $660K | Buy |
+74,113
| New | +$660K | ﹤0.01% | 2871 |
|
|
2021
Q2 | – | Sell |
-3,975
| Closed | -$204K | – | 4000 |
|
|
2021
Q1 | $204K | Sell |
3,975
-13,575
| -77% | -$697K | ﹤0.01% | 3561 |
|
|
2020
Q4 | $470K | Buy |
17,550
+4,150
| +31% | +$111K | ﹤0.01% | 2837 |
|
|
2020
Q3 | $460K | Buy |
13,400
+206
| +2% | +$7.07K | ﹤0.01% | 2679 |
|
|
2020
Q2 | $541K | Buy |
+13,194
| New | +$541K | ﹤0.01% | 2519 |
|